CA
NZ
UK
AU
IND
US
● Cumberland markets branded specialty products, several for hospital and acute-care settings.
● Eocene is the renamed successor to Galmed Pharmaceuticals.
Pfizer is a research-based pharmaceutical company developing andMarketingmedicines and vaccines. Alongside the market action, the company’s P/E multiple of 42.12 and trailing earnings of USD 0.70 a share offer different ways to examine what the quoted price represents. Short-term indicators and longer-term earnings measures …
Eli Lilly is a pharmaceutical company that discovers, develops and markets medicines across areas such as diabetes, obesity, oncology and immunology. Alongside the market action, the company’s P/E multiple of 47.22 and trailing earnings of USD 30.44 a share offer different ways to examine …
Thermo Fisher supplies scientific instruments, laboratory equipment, reagents and services to life sciences, diagnostics and research customers. Alongside the market action, the company’s P/E multiple of 37.87 and trailing earnings of USD 18.95 a share offer different ways to examine what the quoted price …
Amgen is a biotechnology company that discovers, develops and markets therapies for serious illnesses, including cardiovascular disease, oncology and inflammation. Alongside the market action, the company’s P/E multiple of 27.15 and trailing earnings of USD 17.24 a share offer different ways to examine what …
Gilead is a biopharmaceutical company developing medicines for HIV, liver disease, oncology and other serious conditions. Short-term indicators and longer-termEarningsmeasures answer different questions and are best considered separately.
Abbott is a diversified healthcare company with medical devices, diagnostics, nutrition and established pharmaceutical products. Alongside the market action, the company’s P/E multiple of 40.35 and trailing earnings of USD 2.71 a share offer different ways to examine what the quoted price represents. Short-term …
Danaher designs and manufactures life sciences, diagnostics, and environmental and applied solutions products. Alongside the market action, the company’s P/E multiple of 38.53 and trailing earnings of USD 6.11 a share offer different ways to examine what the quoted price represents. Short-term indicators and …
Intuitive Surgical develops robotic-assisted surgical systems and related instruments and services. Alongside the market action, the company’s P/E multiple of 54.39 and trailing earnings of USD 8.27 a share offer different ways to examine what the quoted price represents. Short-term indicators and longer-term earnings …
Please wait processing your request...